• FDA deficiency and Additional Information (AI) response strategy
  • Warning Letter response: root cause analysis, CAPA, and response drafting
  • FDA Form 483 response: observation-by-observation strategy
  • Recall strategy, classification planning, and FDA coordination
  • Field Safety Corrective Action (FSCA) planning and documentation
  • Consent Decree advisory and Import Alert response strategy
  • Lifecycle management: modifications, line extensions, and new indications